Dose curve [PK / PD]

posted by Sundar.M – India, 2019-02-15 14:37 (2676 d 16:02 ago) – Posting: # 19925
Views: 3,260

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN

Complete thread:

UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
143 visitors (0 registered, 143 guests [including 29 identified bots]).
Forum time: 07:40 CEST (Europe/Vienna)

The idea is to try and give all the information to help others
to judge the value of your contribution;
not just the information that leads to judgment
in one particular direction or another.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5